High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma

Bone Marrow Transplantation

Volumn 31, Issue 4, 2003, Pages 281-284

  Kremens, B ^a   Wieland, R ^a   Reinhard, H ^b   Neubert, D ^f   Beck, J D ^c   Klingebiel, T ^d   Bornfeld, N ^e   Havers, W ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d GOETHE UNIVERSITY   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

^f NONE

Author keywords

Hematopoietic stem cell transplantation; High dose chemotherapy; Retinoblastoma

Indexed keywords

CARBOPLATIN; CARMUSTINE; CISPLATIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA; VINCRISTINE; VINDESINE;

ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW METASTASIS; BONE MARROW RESCUE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CHEMOTHERAPY INDUCED EMESIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG MEGADOSE; ENUCLEATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MALE; MENINX DISORDER; MUCOSA INFLAMMATION; NAUSEA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROGNOSIS; RETINOBLASTOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; CARMUSTINE; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; ETOPOSIDE; EYE ENUCLEATION; EYE NEOPLASMS; FEMALE; HUMANS; MALE; RECURRENCE; RETINOBLASTOMA; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0037296629     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703832     Document Type: Article

References (29)

1. Donaldson SS, Egbert PR, Lee W. In: Pizzo PA, Poplack DG (eds). Principles and Practice of Pediatric Oncology. JB Lippincott: Philadelphia, 1993, pp 683-696.
2. German Childhood Cancer Registry Annual Report 2000, Mainz, Germany, 2002, p 71, available at http://www.Kinderkrebsregister.de
3. Shields CL, Shields JA, Baez K et al. Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer 1994; 73: 692-698.
4. Khelfaoui F, Valdidire P, Auperin A et al. Histopathologic risk factors in retinoblastoma, a retrospective study of 172 patients treated in a single institution. Cancer 1996; 77: 1206-1213.
5. Grabowski EF, Abramson DH. Intraocular und extraocular retinoblastoma. Hematol Oncol Clin North Am 1987; 1: 721-735.
6. Doz F, Khelfaoui F, Mosseri V et al. The role of chemotherapy in orbital involvement of retinoblastoma. The experience of a single institution with 33 patients. Cancer 1994; 74: 722-732.
7. Schwartzman E, Chantado G, Fanddińo A et al. Results of a stage-based-protocol for the treatment of retinoblastoma. J Clin Oncol 1996; 14: 1532-1536.
8. Namouni F, Doz F, Tanguy ML et al. High-dose chemotherapy with carboplatin, etoposide and cyclosphosphamide followed by haematopoietic stem cell rescue in patients with high risk retinoblastoma: a SFOP and SFGM study. Eur J Cancer 1997; 33: 2368-2375.
9. Howarth C, Meyer D, Hustu HO et al. Stage-related combined modality treatment of retinoblastoma. Results of a prospective study. Cancer 1980; 45: 851-858.
10. White L. Chemotherapy in retinoblastoma: current status and future directions. Am J Pediatr Hematol Oncol 1991; 13: 189-201.
11. Pratt CB, Fontanesi J, Chenaille P et al. Chemotherapy for extraocular retinoblastoma. Pediatr Hematol Oncol 1996; 11: 301-309.
12. Doz F, Neuenschwander S, Plantaz D et al. Etoposide and carboplatin in extraocular retinoblastoma: a study by the Société Française d'Oncologie Pédiatrique. J Clin Oncol 1995; 13: 902-909.
13. Bornfeld N, Schüler A, Beckrakis N et al. Preliminary results of primary chemotherapy in retinoblastoma. Klin. Päediatr. 1997; 209: 216-221.
14. Saleh RA, Cross S, Cassano W et al. Metastatic retinoblastoma successfully treated with immunomagnetic purged autologous bone marrow transplantation. Cancer 1988; 62: 2301-2303.
15. Saarinen UM, Sariola H, Hovi L et al. Recurrent disseminated retinoblastoma treated by high-dose chemotherapy, total body irradiation and autologous bone marrow rescue. Am J Pediatr Hematol Oncol 1991; 13: 315-319.
16. Heidemann RL, Cole DE, Balis F et al. Phase I and pharmacoqkinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: evidence for dose-dependent plasma clearance of thiotepa. Cancer Res 1989; 49: 736-741.
17. ÓDwyer PJ, Lacreta F, Engstrom PF et al. Phase I/pharmacokinetic reevaluation of thiotepa. Cancer Res 1991; 51: 3171-3176.
18. Saarinen UM, Hovi L, Mäkipernan A et al. High-dose thiotepa with autologous bone marrow rescue in pediatric solid tumors. Bone Marrow Transplant 1991; 8: 369-376.
19. Lucidarme N, Valteau-Couanet D, Oberlin O et al. Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors. Bone Marrow Transplant 1998; 22: 535-540.
20. Laffay-Cousin I, Hartmann O, Plouvier P et al. High-dose thiotepa and hematopoietic stem cell transplantation in pediatric malignant mesenchymal tumors: a phase II study. Bone Marrow Transplant 2000; 26: 627-632.
21. Eder JP, Elias A, Shea TC et al. A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients. J Clin Oncol 1990; 8: 1239-1245.
22. Pession A, Prete A, Locatelli F et al. Phase I study of high-dose thiotepa with busulfan, etoposide, and autologous stem cell support in children with disseminated solid tumors. Med Pediatr Oncol 1999; 33: 450-454.
23. Worth LL, Tran H, Petropopoulos D et al. Hematopoietic stem cell transplantation for childhood myeloid malignancies after high-dose thiotepa, busulfan and cyclophosphamide. Bone Marrow Transplant 1999; 24: 947-952.
24. Richard L, Heidemann E, Douglass R et al. High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas. J Clin Oncol 1993; 8: 1458-1465.
25. Jonathan L, Goldmann S, Wong M et al. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS-tumors. J Clin Oncol 1996; 9: 2495-2503.
26. Dunkel IJ, Boyett JM, Yates A et al. High-dose carboplatin, thiotepa and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. J Clin Oncol 1998; 16: 222-228.
27. Papadopoulos KP, Garvin JH, Fetell M et al. High-dose thiotepa and etoposide-based regimens with autologous hepatopoietic support for high-risk or recurrent CNS tumors in children and adults. Bone Marrow Transplant 1998; 22: 661-667.
28. Hertzberg H, Kremens B, Velten I et al. Recurrent disseminated retinoblastoma in a 7-year-old-girl treated successfully by high-dose chemotherapy and CD34-selected autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2001; 27: 653-655.
29. Dunkel IJ, Aledo A, Kernan NA et al. Successful treatment of metastatic retinoblastoma. Cancer 2000; 89: 2117-2121.